[bt_section layout="boxed" top_spaced="topExtraSpaced" bottom_spaced="bottomSpaced" skin="dark" full_screen="no" divider="no" back_image="12212" back_color="" back_video="" video_settings="" parallax="0.1" parallax_offset="" el_id="" el_class="" el_style="" vertical_align="btBottomVertical" animation="" animation_back="" animation_impress="" back_video_mp4="" back_video_ogg="" back_video_webm=""][bt_row][bt_column width="1/1" align="left" vertical_align="inherit" border="no_border" cell_padding="default" animation="no_animation" text_indent="no_text_indent" highlight="no_highlight" background_color="" transparent="" el_class="" el_style="" background_image=""][bt_header superheadline="" headline="Latest News " headline_size="large" dash="bottom" subheadline="" el_class="" el_style=""][/bt_header][/bt_column][/bt_row][/bt_section][bt_section layout="boxed" top_spaced="not-spaced" bottom_spaced="not-spaced" skin="inherit" full_screen="no" divider="no" back_image="" back_color="" back_video="" video_settings="" parallax="0.1" parallax_offset="" el_id="" el_class="" el_style="" vertical_align="btBottomVertical" animation="" animation_back="" animation_impress=""][bt_row][bt_column width="1/1" align="left" vertical_align="inherit" border="no_border" cell_padding="default" animation="no_animation" text_indent="no_text_indent" highlight="no_highlight" background_color="" transparent="" el_class="" el_style="" background_image=""][bt_hr top_spaced="topSemiSpaced" bottom_spaced="not-spaced" transparent_border="noBorder" el_class="" el_style=""][/bt_hr][/bt_column][/bt_row][/bt_section]

April 15, 2015 John Nelson

After a patient initiates treatment, the real selling-process begins. More than ever, patients are approaching Rx-trialing with a heavy dose of skepticism. It’s understandable. Oftentimes, long-term treatment is thrust upon patients without time to get comfortable. And sometimes, those patients have healthy fears over side effects. On the other side of the coin, many patients expect treatment to fix everything fast or they diminish the value of Rx treatment altogether (before giving it a real chance).

This net skepticism has fueled – no, skyrocketed – a behavior patients hold dear when trialing treatment. And that is finding the authentic truth – conducting their own in-depth exploratory research into Rx treatment expectations, outside of brand communications. Outside of the brand context is where patients perceive to find this authentic truth and the optimal basis for their own opinions and behaviors toward Rx treatment.

Here, I’ll explore this rising phenomenon a bit more and then present an opportunity for brand adherence communications. Essentially, I’ll show you how to guide patients toward external content, in order to help them find their own, preferred version of the truth. In the end, they want to put the “authentic” puzzle pieces together. If we can help them do that, we can help them feel more comfortable with treatment early on and more receptive to the rewarding possibilities of long-term treatment.

Origins of the truth

A year or so ago, I spent time reflecting on the success of online services such as Angie’s List, Yelp, and others, with large investments into customer review networks. I came to one conclusion: in the digital age, the truth comes from strangers.

My hope is that this speaks to you, as both logically flawed and intuitively accurate. Let me explain. Logically speaking, we put our trust in people/entities we know, or in some cases, those we think we know. In this case, the ol’ saying “never trust a stranger” holds true. But today, we live in a hyper-consumerized world where we have many “long-term relationships” with an array of organizations and companies we really “know” little about (e.g., mobile phone, streaming, cable, grocery delivery, etc.). We expect those companies to meet our expectations or, in other words, be trustworthy.

In many cases, the results have been less than stellar. However, there are exceptions. Brands like Zappos and Wayfair have elevated the benchmark of customer service to a religion – but again, these are exceptions. And, the fault cannot be placed entirely on either side – it’s a combination of consumers and companies. Consumers can exaggerate or even create the problems, yet companies (or brands) aren’t exactly model citizens, when the almighty dollar rules the day.

Regardless of who’s right and who’s wrong, the net result has been a heightened mistrust among consumers. You could even say it’s already hit the boiling point with persistent steam ahead. Who can we trust these days?

The person/entity we often trust is the person/entity with no vested interest in us: the stranger. They don’t want our money, our commitment, or a relationship. They do have opinions, though – invaluable ones about the subjects that matter most to us. And they like to voice these opinions. It’s these anonymous voices we seek in order to find the authentic truth and, as a result, make better decisions.

The patient “truth-seeking” journey

This is the kind of approach patients take when trialing Rx treatment. They get the doctor’s version of the story, they get the brand version (e.g., brochure, site), and then they go looking for the outsider context: the anonymous opinion, the unknown academic perspective, the clinical trial data, the virtuous community site, and even sponsored content, but on a trusted site.

Now, let’s bring these learnings back to the question at hand: how can Rx brands become an integral part of the content system patients tap into when finding their authentic truth?

First, I have to acknowledge that this is not a one-stop shopping experience for patients. They will leverage this behavior at multiple points during treatment. In my experience, the best way to manage this is to glean the most important barriers to short-term, intermediate, and long-term adherence. Typically, short-term issues surround potential side effects, whereas intermediate and long-term issues usually surround side effect experiences, efficacy, and cost.

On the subject of cost, we often think of cost-saving programs benefitting patients just starting treatment. What I’ve learned is that most patients wrestle with treatment value relative to cost, once they’ve come to the conclusion that they’ve experienced said treatment’s full potential. For the commercially insured, if their treatment co-pay is negligible (through a branded support program), they will likely accept average efficacy, for example, and stay on treatment longer.

So, how do we use branded content to encourage adherence, while embracing a patient’s journey to find the authentic truth? Below are five recommendations to help you, and your patients, succeed:

  1. Use a trustworthy environment to evolve your brand marketing into brand truth.
  2. Market clinical studies without feeling like your marketing clinical studies.
  3. Gain their trust by setting them free.
  4. Let patients – even help them – find the good and bad about your brand.
  5. Lastly, recognize how search can unearth issues patients were never searching for.

Patients hold all the power these days. Let’s help them realize that dream… and get rewarded for it.

EDITOR’S NOTE: This is a condensed version of John’s article. To read the full-length feature and learn more about the five recommendations for the authentic truth, check out his upcoming article in the 2015 annual issue of DTC Perspectives Magazine out next month.

About the Author:
John Nelson has spent over 13 years in advertising, working with some of the most iconic health brands of our time. In his role as VP, Strategic Planning at Evoke Health New York, John is responsible for inspiring strategy that creates big ideas and big connections between brands and people – connections that drive behavior change and deliver tangible results for clients. He can be reached at john.nelson@evokehealth.com.